Evidence map›Paper›PMID 21224054›Full record

ArticleThe American journal of pathology2011

Perturbations in ataxia telangiectasia mutant signaling pathways after drug-induced acute liver failure and their reversal during rescue of animals by cell therapy.

Sriram Bandi, Brigid Joseph, Ekaterine Berishvili, Rohit Singhania, Yao-Ming Wu, Kang Cheng, Sanjeev Gupta

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Cell therapy to remove excess copper in Wilson's disease.Annals of the New York Academy of Sciences · 2014
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Sriram BandiDepartment of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA.
Brigid Joseph
Ekaterine Berishvili
Rohit Singhania
Yao-Ming Wu
Kang Cheng
Sanjeev Gupta
Albert Einstein College of Medicine · US

Funding

Special Animal CoreP30DK041296 · NIDDK · YESHIVA UNIVERSITY · PI WOLKOFF, ALLAN W · 1989 to 2018
$22.9M
Transplantation of Endothelial CellsR01DK071111 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI GUPTA, SANJEEV · 2006 to 2016
$3.6M
NIDDK NIH HHS P30 DK041296NIDDK NIH HHS P30-DK41296NIDDK NIH HHS R01 DK071111
6 · The paper itself

Abstract

Superior insights into molecular mechanisms of liver failure, which are not fully understood, will help strategies for inducing liver regeneration. We examined hepatotoxic mechanisms in mice homozygous for the severe combined immune deficiency mutation in the protein kinase, DNA-activated, catalytic polypeptide. Mice were treated with rifampicin, phenytoin, and monocrotaline. The ensuing acute liver failure was characterized by serological, histological, and mRNA studies. Subsequently, we studied whether transplantation of hepatocytes could rescue animals with liver failure. We found extensive liver damage in these animals, with mortality over several days. The expression of multiple hepatic genes was rapidly altered, including those representing pathways in oxidative/metabolic stress, inflammation, DNA damage-repair, and ataxia telangiectasia mutant (Atm) signaling pathways. This led to liver cell growth arrest involving cyclin-dependent kinase inhibitor 1A. Transplantation of hepatocytes with microcarriers in the peritoneal cavity efficiently rescued animals with liver failure. Molecular abnormalities rapidly reversed, including in hepatic Atm and downstream signaling pathways; and residual hepatocytes overcame cyclin-dependent kinase inhibitor 1A-induced cell growth arrest. Reseeding of the liver with transplanted hepatocytes was not required for rescue because native hepatocytes overcame cell growth-arrest to regenerate the liver. This likely resulted from paracrine signaling from hepatocytes in the peritoneal cavity. We concluded that Atm signaling played critical roles in the pathological features of liver failure. These studies should help redirect examination of pathophysiologic and therapeutic mechanisms in liver failure.

Indexed as

AnimalsAtaxia Telangiectasia Mutated ProteinsCell Cycle ProteinsCell ProliferationCyclin-Dependent Kinase Inhibitor p21Cytochrome P-450 CYP3ADNA-Binding ProteinsDNA DamageDNA RepairGene ExpressionHepatocytesLiver Failure, AcuteLiver RegenerationMiceMice, SCIDMonocrotalineAtaxia Telangiectasia Mutated ProteinsAtm protein, mouseCell Cycle ProteinsCyclin-Dependent Kinase Inhibitor p21Cytochrome P-450 CYP3ADNA-Binding ProteinsMonocrotalinePhenytoinProtein Serine-Threonine KinasesRifampinTumor Suppressor Proteins

Identifiers

PMID21224054
PMCPMC3069839
OpenAlexW2064366853

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.